H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on PepGen (PEPG) to $14 from $16 and keeps a Buy rating on the shares after the company announced that the results from the PGN-EDO51 cohort from the CONNECT1 cohort are scheduled to readout in Q3.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEPG:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue